drugset / Trial / NCT03733470

Hypoxic Pulmonary Vasoconstriction Pilot Study

NCT03733470

Non-randomizedSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to determine if the events leading to smoking-associated centrilobular and paraseptal emphysema are caused by a failure of the lungs' inherent mechanisms to block hypoxic pulmonary vasoconstriction (HPV) in areas of smoking-induced inflammation.

Timeline

Start
2011-06-29
Primary completion
2014-01-13
Completion
2014-01-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 20 mg

Indications